Search Results

There are 16966 results for: content related to: Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences

  1. You have free access to this content
    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

    Hepatology

    Volume 34, Issue 4, October 2001, Pages: 785–791, Man-Fung Yuen, Erwin Sablon, Prof. Chee-Kin Hui, He-Jun Yuan, Hilde Decraemer and Ching-Lung Lai

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.27563

  2. You have free access to this content
    Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

    Hepatology

    Volume 27, Issue 6, June 1998, Pages: 1711–1716, Kazuaki Chayama, Yoshiyuki Suzuki, Masahiro Kobayashi, Mizuho Kobayashi, Akihito Tsubota, Michie Hashimoto, Yukiko Miyano, Hiromi Koike, Mariko Kobayashi, Isao Koida, Yasuji Arase, Satoshi Saitoh, Naoya Murashima, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510270634

  3. Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients

    Journal of Medical Virology

    Volume 60, Issue 1, January 2000, Pages: 8–16, Toshikatsu Seta, Osamu Yokosuka, Fumio Imazeki, Masami Tagawa and Hiromitsu Saisho

    Version of Record online : 19 NOV 1999, DOI: 10.1002/(SICI)1096-9071(200001)60:1<8::AID-JMV2>3.0.CO;2-U

  4. Virological and biochemical relapse according to YMDD motif mutant type during long-term lamivudine monotherapy

    Journal of Medical Virology

    Volume 71, Issue 4, December 2003, Pages: 504–510, Norio Akuta, Fumitaka Suzuki, Mariko Kobayashi, Marie Matsuda, Junko Sato, Kimiko Takagi, Akihito Tsubota, Yoshiyuki Suzuki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 6 OCT 2003, DOI: 10.1002/jmv.10519

  5. You have free access to this content
    Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

    Hepatology

    Volume 29, Issue 3, March 1999, Pages: 889–896, Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Jenny Heathcote, Maria Buti, Robert D. Goldin, Sasha Hawley, Judy Barber, Lynn Condreay and D. Fraser Gray

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510290321

  6. You have free access to this content
    Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

    Hepatology

    Volume 30, Issue 2, August 1999, Pages: 567–572, Yun-Fan Liaw, Rong-Nan Chien, Chau-Ting Yeh, Sun-Lung Tsai and Chia-Ming Chu

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510300221

  7. You have free access to this content
    Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

    Hepatology

    Volume 33, Issue 6, June 2001, Pages: 1527–1532, Nancy W. Y. Leung, Ching-Lung Lai, Ting-Tsung Chang, Richard Guan, Chuan-Mo Lee, Keng-Yeen Ng, Seng-Gee Lim, Pui-Chee Wu, Julie C. Dent, Sally Edmundson, Lynn D. Condreay and Rong-Nan Chien

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.25084

  8. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  9. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  10. You have free access to this content
    YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull-length viral DNA transfection

    Hepatology

    Volume 29, Issue 3, March 1999, Pages: 939–945, Suzane Kioko Ono-Nita, Naoya Kato, Yasushi Shiratori, Tsutomu Masaki, Keng-Hsin Lan, Flair José Carrilho and Masao Omata

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510290340

  11. You have free access to this content
    Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

    Hepatology

    Volume 31, Issue 6, June 2000, Pages: 1318–1326, Chau-Ting Yeh, Rong-Nan Chien, Chia-Ming Chu and Yun-Fan Liaw

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2000.7296

  12. Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: An 8-year follow-up study

    Journal of Medical Virology

    Volume 75, Issue 4, April 2005, Pages: 491–498, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi and Hiromitsu Kumada

    Version of Record online : 15 FEB 2005, DOI: 10.1002/jmv.20305

  13. You have free access to this content
    A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation

    Liver Transplantation

    Volume 7, Issue 6, June 2001, Pages: 504–510, Robert J. Fontana, Hie-Won L. Hann, Teresa Wright, Gregory Everson, Alfred Baker, Eugene R. Schiff, Carolyn Riely, Gaya Anschuetz, Melanie Riker-Hopkins and Nathaniel Brown

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jlts.2001.24896

  14. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  15. You have free access to this content
    Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

    Hepatology

    Volume 27, Issue 6, June 1998, Pages: 1670–1677, Marchelle I. Allen, Manon Deslauriers, C. Webster Andrews, Graham A. Tipples, Kathie-Anne Walters, David L. Tyrrell, Nathaniel Brown and Lynn D. Condreay

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510270628

  16. Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: A single center experience

    Journal of Medical Virology

    Volume 75, Issue 3, March 2005, Pages: 391–398, Jian Sun, Zhanhui Wang, Shiwu Ma, Guobing Zeng, Zhiyong Zhou, Kangxian Luo and Jinlin Hou

    Version of Record online : 12 JAN 2005, DOI: 10.1002/jmv.20281

  17. Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients

    Pediatrics International

    Volume 47, Issue 4, August 2005, Pages: 372–377, Yen-Hsuan Ni, Fu-Chen Huang, Tzee-Chung Wu, Man-Shan Kong, Yung-Ming Jeng, Pei-Jer Chen, Daw-Jen Tsuei, Huey-Ling Chen, Hong-Yuan Hsu and Mei-Hwei Chang

    Version of Record online : 29 JUL 2005, DOI: 10.1111/j.1442-200x.2005.02101.x

  18. You have free access to this content
    Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B

    Hepatology

    Volume 32, Issue 5, November 2000, Pages: 1078–1088, Si Nafa Si Ahmed, David Tavan, Christian Pichoud, Françoise Berby, Lieven Stuyver, Mark Johnson, Philippe Merle, Hassane Abidi, Christian Trépo and Fabien Zoulim

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2000.19619

  19. You have free access to this content
    Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy

    Hepatology

    Volume 32, Issue 5, November 2000, Pages: 1163–1169, Sung Won Cho, Ki-Baik Hahm and Jin Hong Kim

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2000.19618

  20. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine

    Journal of Medical Virology

    Volume 74, Issue 2, October 2004, Pages: 361–366, Marie Matsuda, Fumitaka Suzuki, Yoshiyuki Suzuki, Akihito Tsubota, Norio Akuta, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Junko Satoh, Mariko Kobayashi, Kenji Ikeda, Yuzo Miyakawa and Hiromitsu Kumada

    Version of Record online : 20 AUG 2004, DOI: 10.1002/jmv.20185